These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30605294)

  • 1. Influence of leukotriene receptor antagonist on contractile activity of the porcine uterine smooth muscle in the luteal phase and in early pregnancy.
    Markiewicz W; Wiśniewska A; Madej-Śmiechowska H; Burmańczuk A; Jaroszewski JJ
    Pol J Vet Sci; 2018 Dec; 21(4):823-825. PubMed ID: 30605294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antenatal montelukast treatment reduces uterine activity associated with inflammation in a pregnant rat model.
    Corriveau S; Blouin S; Burt E; Rousseau E; Pasquier JC
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():92-98. PubMed ID: 27649459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene receptor antagonist as a novel tocolytic in an in vitro model of human uterine contractility.
    Corriveau S; Rousseau É; Blouin S; Pasquier JC
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():77-83. PubMed ID: 24735655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of β2- and β3-adrenoceptor agonists on contractile activity of the porcine myometrium in the luteal phase and the first days of pregnancy.
    Markiewicz W; Jaroszewski JJ
    Pol J Vet Sci; 2017 Mar; 20(1):111-121. PubMed ID: 28525334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cysteinyl leukotrienes on uterine strips from pregnant and non-pregnant swine].
    Ledwozyw A; Kadziołka A
    Pol Arch Weter; 1989; 29(3-4):79-92. PubMed ID: 2562080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?
    El-Sisi Ael-D; Sokar SS; Salem TA; Abu Risha SE
    Toxicol Ind Health; 2015 Nov; 31(11):1024-36. PubMed ID: 26499992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat.
    Sener G; Sehirli O; Toklu H; Ercan F; Alican I
    J Pharm Pharmacol; 2007 Jun; 59(6):837-42. PubMed ID: 17637175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cysteinyl leukotriene receptors on human saphenous veins: antagonist activity of montelukast and its metabolites.
    Mechiche H; Candenas L; Pinto FM; Nazeyrollas P; Clément C; Devillier P
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):113-20. PubMed ID: 14668576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist.
    Jones TR; Labelle M; Belley M; Champion E; Charette L; Evans J; Ford-Hutchinson AW; Gauthier JY; Lord A; Masson P
    Can J Physiol Pharmacol; 1995 Feb; 73(2):191-201. PubMed ID: 7621356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Montelukast, a selective cysteinyl leukotriene receptor 1 antagonist, reduces cerulein-induced pancreatic injury in rats.
    Ozkan E; Akyüz C; Sehirli AO; Topaloğlu U; Ercan F; Sener G
    Pancreas; 2010 Oct; 39(7):1041-6. PubMed ID: 20467345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle.
    Fogli S; Stefanelli F; Martelli A; Daniele S; Testai L; Calderone V; Trincavelli ML; Martini C; Breschi MC
    Pulm Pharmacol Ther; 2013 Dec; 26(6):693-9. PubMed ID: 23810957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.
    Kuo CH; Yang SN; Kuo HF; Lee MS; Huang MY; Huang SK; Lin YC; Hsieh CC; Hung CH
    Pulm Pharmacol Ther; 2016 Aug; 39():28-37. PubMed ID: 27312202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig.
    Harrison S; Gatti R; Baraldo S; Oliani KL; Andre E; Trevisani M; Gazzieri D; Saetta M; Geppetti P
    Pulm Pharmacol Ther; 2008; 21(2):317-23. PubMed ID: 17905619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
    Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
    Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the leukotriene receptor antagonist montelukast on orthodontic tooth movement.
    Asaad H; Al-Sabbagh R; Al-Tabba D; Kujan O
    J Oral Sci; 2017; 59(2):297-302. PubMed ID: 28637990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field.
    Hoxha M; Rovati GE; Cavanillas AB
    Eur J Clin Pharmacol; 2017 Jul; 73(7):799-809. PubMed ID: 28374082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
    Shiota N; Shimoura K; Okunishi H
    Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of acetylcholine and its receptors in the contractility of inflamed porcine uterus.
    Jana B; Całka J; Bulc M; Piotrowska-Tomala KK
    Theriogenology; 2020 Feb; 143():123-132. PubMed ID: 31874364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
    Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
    Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.